Spots Global Cancer Trial Database for cutaneous neurofibroma
Every month we try and update this database with for cutaneous neurofibroma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) | NCT04435665 | Neurofibromatos... Cutaneous Neuro... | NFX-179 Gel Vehicle Gel | 18 Years - | NFlection Therapeutics, Inc. | |
| Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma | NCT02839720 | Cutaneous Neuro... Neurofibromatos... Optic Nerve Gli... | Laboratory Biom... Selumetinib Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 | NCT03090971 | Neurofibromatos... Cutaneous Neuro... | Diclofenac Sodi... Saline Solution | 18 Years - | Fundação Educacional Serra dos Órgãos | |
| DPCP to Treat Cutaneous Neurofibromas Associated With NF1 | NCT05438290 | Cutaneous Neuro... | DPCP | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Natural History Study of Cutaneous Neurofibromas in People With NF1 | NCT05581511 | Neurofibromatos... Neurofibromatos... Neurofibromatos... Cutaneous Neuro... | Evaluation of t... | 1 Year - 100 Years | Johns Hopkins University | |
| Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 | NCT03090971 | Neurofibromatos... Cutaneous Neuro... | Diclofenac Sodi... Saline Solution | 18 Years - | Fundação Educacional Serra dos Órgãos | |
| DPCP to Treat Cutaneous Neurofibromas Associated With NF1 | NCT05438290 | Cutaneous Neuro... | DPCP | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) | NCT05005845 | Cutaneous Neuro... Neurofibromatos... | NFX-179 gel Vehicle gel | 18 Years - | NFlection Therapeutics, Inc. | |
| Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma | NCT02839720 | Cutaneous Neuro... Neurofibromatos... Optic Nerve Gli... | Laboratory Biom... Selumetinib Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). | NCT06159166 | NF1 Cutaneous Neuro... Monotherapy | Mirdametinib | 18 Years - | Johns Hopkins University | |
| Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas | NCT04730583 | Cutaneous Neuro... | Kybella 1064nm laser 755nm Alexandri... | 18 Years - 85 Years | Massachusetts General Hospital | |
| HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy | NCT05119582 | Cutaneous Neuro... | TOOsonix System... | 18 Years - | Bispebjerg Hospital | |
| Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas | NCT04730583 | Cutaneous Neuro... | Kybella 1064nm laser 755nm Alexandri... | 18 Years - 85 Years | Massachusetts General Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
